WO2019246615A1 - Apparatus, systems, and methods for continuous manufacturing of nanomaterials and high purity chemicals - Google Patents
Apparatus, systems, and methods for continuous manufacturing of nanomaterials and high purity chemicals Download PDFInfo
- Publication number
- WO2019246615A1 WO2019246615A1 PCT/US2019/038705 US2019038705W WO2019246615A1 WO 2019246615 A1 WO2019246615 A1 WO 2019246615A1 US 2019038705 W US2019038705 W US 2019038705W WO 2019246615 A1 WO2019246615 A1 WO 2019246615A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- microreactor
- stream
- feed
- line mixer
- pump
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0093—Microreactors, e.g. miniaturised or microfabricated reactors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
- B01F23/40—Mixing liquids with liquids; Emulsifying
- B01F23/41—Emulsifying
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
- B01F23/40—Mixing liquids with liquids; Emulsifying
- B01F23/41—Emulsifying
- B01F23/4105—Methods of emulsifying
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
- B01F25/20—Jet mixers, i.e. mixers using high-speed fluid streams
- B01F25/23—Mixing by intersecting jets
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
- B01F25/40—Static mixers
- B01F25/42—Static mixers in which the mixing is affected by moving the components jointly in changing directions, e.g. in tubes provided with baffles or obstructions
- B01F25/43—Mixing tubes, e.g. wherein the material is moved in a radial or partly reversed direction
- B01F25/431—Straight mixing tubes with baffles or obstructions that do not cause substantial pressure drop; Baffles therefor
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F33/00—Other mixers; Mixing plants; Combinations of mixers
- B01F33/30—Micromixers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F35/00—Accessories for mixers; Auxiliary operations or auxiliary devices; Parts or details of general application
- B01F35/20—Measuring; Control or regulation
- B01F35/21—Measuring
- B01F35/211—Measuring of the operational parameters
- B01F35/2111—Flow rate
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F35/00—Accessories for mixers; Auxiliary operations or auxiliary devices; Parts or details of general application
- B01F35/20—Measuring; Control or regulation
- B01F35/22—Control or regulation
- B01F35/221—Control or regulation of operational parameters, e.g. level of material in the mixer, temperature or pressure
- B01F35/2211—Amount of delivered fluid during a period
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F35/00—Accessories for mixers; Auxiliary operations or auxiliary devices; Parts or details of general application
- B01F35/71—Feed mechanisms
- B01F35/717—Feed mechanisms characterised by the means for feeding the components to the mixer
- B01F35/7176—Feed mechanisms characterised by the means for feeding the components to the mixer using pumps
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F35/00—Accessories for mixers; Auxiliary operations or auxiliary devices; Parts or details of general application
- B01F35/90—Heating or cooling systems
- B01F35/92—Heating or cooling systems for heating the outside of the receptacle, e.g. heated jackets or burners
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F35/00—Accessories for mixers; Auxiliary operations or auxiliary devices; Parts or details of general application
- B01F35/90—Heating or cooling systems
- B01F2035/99—Heating
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F2101/00—Mixing characterised by the nature of the mixed materials or by the application field
- B01F2101/2204—Mixing chemical components in generals in order to improve chemical treatment or reactions, independently from the specific application
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
- B01F23/40—Mixing liquids with liquids; Emulsifying
- B01F23/41—Emulsifying
- B01F23/414—Emulsifying characterised by the internal structure of the emulsion
- B01F23/4145—Emulsions of oils, e.g. fuel, and water
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00781—Aspects relating to microreactors
- B01J2219/00788—Three-dimensional assemblies, i.e. the reactor comprising a form other than a stack of plates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00781—Aspects relating to microreactors
- B01J2219/00788—Three-dimensional assemblies, i.e. the reactor comprising a form other than a stack of plates
- B01J2219/00792—One or more tube-shaped elements
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00781—Aspects relating to microreactors
- B01J2219/00851—Additional features
- B01J2219/00858—Aspects relating to the size of the reactor
- B01J2219/0086—Dimensions of the flow channels
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00781—Aspects relating to microreactors
- B01J2219/00873—Heat exchange
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00781—Aspects relating to microreactors
- B01J2219/00889—Mixing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00781—Aspects relating to microreactors
- B01J2219/00891—Feeding or evacuation
Definitions
- the present disclosure is directed to apparatus, systems, and methods that
- the disclosed apparatus, systems, and methods are designed to enhance mixing of continuous streams of liquids that are fed into a microreactor so as to produce nanomaterials, enhance the rates of chemical reactions, or improve the purity of the products of the chemical reactions.
- the intensity of turbulence generally influences the size of particles that are dispersed throughout a fluid, the quality of an emulsion, and the residence time distribution profiles that determine progress and selectivity of chemical reactions. This is particularly apparent in the emerging nanotechnologies, where precipitation and crystallization processes have a significant impact on product quality.
- mixing characteristics influence and/or determine the performance of reaction vessels, at both laboratory and production scales, and properly designed/implemented mixing systems can permit and/or facilitate the use of continuous systems, in lieu of batch systems, to enhance productivity.
- cavitation has been used in industry for homogenization operations, i.e., to disperse suspended particles in colloidal liquids.
- cavitation-based mixing is often employed with solids, it may not be the best choice for generation of nanoemulsions and vesicle loading, as in drug chaperones.
- Cavitation can result in issues associated with materials of construction and/or scale-up issues for mixing device fabrication.
- a liquid through an annular opening that has a narrow entrance orifice with a much larger exit orifice, a dramatic decrease in pressure results in fluid acceleration into a larger volume and generation of cavitation bubbles.
- the surface upon which these bubbles collide is subjected to tremendous stresses.
- High pressure homogenizers utilize high shear to create small particles.
- the technologies described hereinabove require multi-step processes and are energy intensive. Such technologies require first mixing all of the ingredients with a relatively low energy device and then processing with a high pressure homogenizer of a cavitation device several times, until the product quality is achieved.
- Nano-emulsions, liposomes and other generalized cargo loaded systems can only encapsulate a limited amount of drug. Therefore, current approaches may not be the strategies of choice for drugs with high dosage demands. Nanosuspensions can deliver much larger amounts of drug in a smaller volume than solvent-diluted drug systems and, therefore, may have a potential advantage as a formulation strategy when a high dose is required. Further, these conventional methods have high energy demands and are multi-step. [0008] Most often, nanosuspensions are produced by milling, micronizing or high shear processing. Thus, current methods for manufacturing nanosuspensions primarily rely on the reduction of particle size of drug powders in dry or wet formulations.
- Such“top-down” processes are generally slow, require repetitive processing cycles, and require substantial energy. Indeed, the targeted particle sizes, usually less than 0.5 microns, are often time consuming and expensive to produce, frequently requiring repetitive processing cycles/passes through the milling/high shear equipment to achieve desired particle size distributions.
- Crystallization is a method that is used to produce fine chemicals and
- Greenwood et al. disclose a sterilizable particle-size reduction apparatus in WO
- Kipp et al. disclose methods/apparatus for generating submicron particle suspensions that involves mixing a solution that contains a pharmaceutically active compound that is dissolved in a water-miscible solvent with a second solvent to form a pre-suspension of particles and then energizing the mixture to form a particle suspension having an average particle size of less than 100 pm (see U.S. Patent Publications 2003/0206959 and 2004/0266890; U.S.
- U.S. Pat. No. 6,558,435 to Am Ende et al. discloses a process for synthesis/crystallization of a pharmaceutical compound that involves contacting diametrically opposed liquid jet streams, such that the liquid streams meet at a point of impingement to create a vertical impingement film and create turbulence at their point of impact under conditions of temperature and pressure which permit reaction of reactive intermediates to produce a product.
- the jet streams are disclosed to have sufficient linear velocity to achieve micromixing of the jet stream constituents, followed by reaction and nucleation to form high surface area crystals. See also U.S. Patent Publication No. 2006/0151899 to Kato et al.
- apparatus, systems, and methods for achieving interaction of constituents within an interaction chamber to promote mixing and/or reaction phenomena.
- apparatus, systems, and methods disclosed in the‘554 and‘004 patents have significant shortcomings.
- One shortcoming is such apparatus, systems, and methods result in a nano- or micro-particle formulation having incorrect proportions of constituents.
- the apparatus, systems, and methods of the‘554 and‘004 patents describe two feed streams that are directly fed to an intensifier pump at different individually actively controlled rates such that interaction between the two feed streams is substantially prevented prior to pressurization within the intensifier pump, thereby, avoiding potential reactions and other constituent interactions prior to micro- and/or nano-scale interactions within the interaction chamber described therein.
- such a system uses a first pump to control a first feed stream, a second pump to control a second feed stream, and an intensifier pump to control the mixture of first feed stream and the second feed stream (i.e., the inputs and outputs are being controlled).
- a first pump to control a first feed stream
- a second pump to control a second feed stream
- an intensifier pump to control the mixture of first feed stream and the second feed stream (i.e., the inputs and outputs are being controlled).
- it would seem advantageous to actively control the flow rate of the system by actively controlling each feed stream e.g., attempting to have each feed stream enter the system, flow through the system, and exit the system at the same flow rate.
- Such difficulties arise because the flow rates are pulsating rather than being completely constant, which results in a sufficient flow rate not being achieved.
- the flow rate is a processing rate that is too low or too high.
- Such an insufficient flow rate results in a disruption of the desired ratio of the constituents of the feed streams and ultimately failure to achieve the desired micro- and/or nano particle formulation.
- a lack of control of the flow rate of the system can make scale up very problematic.
- Another shortcoming is that a primary goal of the apparatus, systems, and
- ‘554 and‘004 patents provide insufficient time to achieve certain desired processes and chemical reactions.
- the first and second feed streams only pass through an intensifier pump and a reaction chamber.
- a typical residence time for an intensifier pump is commonly about 1 or 2 seconds but a process may require as high as about 40 seconds.
- a common residence time for a reaction chamber is about 1 millisecond. Given such a minimal time frame to conduct a process in the apparatus, systems, and methods disclosed in the‘554 and‘004 patents, many desirable processes and chemical reactions that require more time would not be possible.
- the present disclosure addresses the problems described above by providing the disclosed systems/apparatus and methods for continuously processing at least two liquid feed streams.
- One aspect of the present disclosure provides a method for continuously processing at least two liquid feed streams.
- the method comprises: pumping a first feed stream to an in-line mixer at an actively automatically controlled rate; flowing a second feed stream to the in-line mixer; mixing the first and second feed streams to achieve a substantially homogeneous mixture; pumping the substantially homogeneous mixture to a high pressure pump at an actively controlled rate; pressurizing the substantially homogeneous mixture within the high pressure pump to an elevated pressure of at least 35 MPa; and delivering the substantially homogeneous mixture to a microreactor downstream from the high pressure pump.
- the microreactor has a minimum channel dimension of 500 microns or less, causing the first and second liquid streams to interact within the microreactor at a nanoscale level.
- the first feed stream includes a first constituent and the second feed stream includes a second constituent.
- the first and second feed streams are delivered to the in-line mixer in feed lines that are coaxially aligned.
- the first and second feed streams are introduced to the in-line mixer through spaced ports defined by the in-line mixer.
- the actively controlled rate for delivery of the first feed stream to the in-line mixer is effected by an actively controlled feed pump for the first feed stream.
- the method further comprises cooling or quenching the substantially homogenous mixture after interaction within the microreactor.
- the first constituent includes a solvent and the second constituent includes an antisolvent.
- interaction of the solvent and the antisolvent in the microreactor is effective to define a nanosuspension.
- the method further comprises obtaining constituent nanoparticle crystals from the
- the solvent stream is selected from the group consisting of dimethyl sulfoxide (DMSO), N-Methyl-2-Purrolidone (NMP), methanol, ethanol, acetone, dichloromethane, octanol and isopropyl alcohol.
- the antisolvent stream is selected from the group consisting of water, hexane and heptane.
- the solvent stream is DMSO and nanoparticles of azithromycin are obtained at a median particle size of about 50-100 nm.
- the solvent stream is DMSO and nanoparticles of oxycarbazepine are obtained at a median particle size less than 1000 nm. In some embodiments, the solvent stream is DMSO or NMP and nanoparticles of loratadine are obtained at a median particle size of less than 500 nm. In some embodiments, the method further comprises cooling or quenching the nanosuspension after interaction within the microreactor.
- the elevated pressure is at least about 70 MPa. In some embodiments, the elevated pressure is at least about 140 MPa. In some embodiments, the elevated pressure is at least about 207 MPa. In some embodiments, the ratio of the flow rate of the second stream to the flow rate of the first stream is at least about 2: 1. In some embodiments, the ratio of the flow rate of the second stream to the flow rate of the first stream is at least about 3: 1. In some embodiments, the ratio of the flow rate of the second stream to the flow rate of the first stream is at least about 10: 1.
- the microreactor has channels with minimum dimensions in the range of 10-500 microns.
- the average fluid velocity in the microreactor has channels with minimum dimensions in the range of 10-500 microns.
- microreactor channels is in the range of 300-500 m/s.
- the method further comprises effecting a sheer rate in the microreactor of at least about 1 2x 10 6 s _1 .
- the microreactor has a single slot geometry.
- at least one of the liquid feed streams includes solid particles.
- at least one of the feed streams contains seed particles.
- at least one of the feed streams contains catalyst particles.
- the first constituent is a first reactant and the second constituent is a second reactant.
- the method further comprises adjusting reaction selectivity by controlling interaction between the first and second reactants prior to the nanoscale level interaction within the microreactor.
- control of the interaction between the first and second reactants is effected by encouraging contact between the first and second reactants in the in-line mixer prior to pressurization in the high pressure pump so as to achieve the substantially homogeneous mixture.
- the substantially homogeneous mixture is pumped to the high pressure pump through a port defined by the high pressure pump.
- the method further comprises cooling or quenching the substantially homogeneous mixture after reaction within the microreactor.
- the first and second feed streams are immiscible. In some embodiments, the first and second feed streams are miscible. In some embodiments, the constituents interact within the microreactor to achieve an emulsion, a dispersion, a liposomal formulation, lipid nanoparticles, or a crystalline or amorphous material. In some embodiments, the first feed stream is an oil phase and the second feed stream is a water phase.
- the oil phase is selected from a vegetable oil, a nut oil, an animal oil, an inorganic oil, a lipid, a surfactant, a polymer, an active ingredient, a flavoring, a coloring, an alcohol, an organic solvent, and/or a derivative thereof.
- the water phase is selected from water, lipid, surfactant, viscosity modifier, pH adjuster, and sugar.
- the first feed stream is a water phase and the second feed stream is an oil phase.
- the oil phase is selected from a vegetable oil, a nut oil, an animal oil, an inorganic oil, a lipid, a surfactant, a polymer, an active ingredient, a flavoring, a coloring, an alcohol, an organic solvent, and/or a derivative thereof.
- the water phase is selected from water, lipid, surfactant, viscosity modifier, pH adjuster, and sugar.
- Another aspect of the present disclosure provides a system for continuously
- the system comprises a feed pump that is adapted to pump a first feed stream downstream at an actively automatically controlled rate; an in-line mixer positioned to receive the first feed stream from the feed pump and a second feed stream from a feed line; a high pressure pump positioned to receive the substantially homogeneous mixture from the in-line mixture; and a microreactor downstream of the high pressure pump.
- the in-line mixer is adapted to mix the first and second feed streams to achieve a substantially homogeneous mixture.
- the microreactor has a minimum channel dimension of 500 microns or less.
- the microreactor is adapted to effect high shear fields so as to achieve thorough mixing of the substantially homogeneous mixture.
- the feed pump is a metering pump.
- the first and second feed streams are delivered to the in-line mixer in a coaxial arrangement.
- the microreactor has a single slot geometry.
- the system further comprises a cooling unit downstream of the microreactor.
- the in-line mixer includes a plurality of spaced feed ports.
- the first feed stream is introduced to the in-line mixer through a first feed port and the second feed stream is introduced to the in-line mixer through a second feed port.
- the first feed stream includes a first constituent and the second feed stream includes a second constituent.
- the microreactor is adapted to effect a controlled nanoscale interaction between the first constituent and the second constituent.
- the microreactor is adapted to effect interaction of a first reactant in the first feed stream and a second reactant in the second feed stream at a nanoscale level.
- the system is configured so that reaction selectivity can be controlled by controlling interaction between the first and second reactants prior to the nanoscale level interaction within the microreactor.
- control of the interaction between the first and second reactants is effected by encouraging contact between the first and second reactants in the in-line mixer prior to pressurization in the high pressure pump so as to achieve the substantially homogeneous mixture.
- the first and second reactants are delivered to the in-line mixer through spaced ports defined by the in-line mixer.
- the elevated pressure is at least about 70 Mpa. In some embodiments, the elevated pressure is at least about 140 MPa. In some embodiments, the elevated pressure is at least about 207 MPa.
- the ratio of the flow rate of the second stream to the flow rate of the first stream is at least about 2: 1. In some embodiments, the ratio of the flow rate of the second stream to the flow rate of the first stream is at least about 3: 1. In some embodiments, the ratio of the flow rate of the second stream to the flow rate of the first stream is at least about 10: 1.
- the microreactor has channels with minimum dimensions in the range of 10-500 microns.
- the average fluid velocity in the microreactor has channels with minimum dimensions in the range of 10-500 microns.
- microreactor channels is in the range of 300-500 m/s. In some embodiments, the sheer rate effected in the microreactor is at least about 1 2x 10 6 s _1 . In some embodiments, the microreactor has a single geometry.
- Micro-scale apparatus, systems and methods are provided according to the present disclosure that facilitate and utilize microreactor technology to achieve desired mixing and interaction at a micro and/or molecular level between and among feed stream constituents.
- the disclosed apparatus, systems and methods are capable of various degrees of mixing intensity and control of energy dissipation mechanisms, thereby maximizing useful work in forming surfaces and interfaces between and among constituent molecules/compounds.
- the present disclosure permits advantageous reductions in system entropy that might be otherwise experienced due to process inefficiencies. Such entropy reduction is a major benefit standing alone, but also translates to minimizing energy lost to heat, sound, light and cavitation. Indeed, reduced system entropy advantageously further translates to a reduced propensity for component damage.
- exemplary embodiments/implementations of the disclosed apparatus, systems and methods are adapted to function in environments that require portability, thereby providing enhanced flexibility in applications and in-use time.
- solvent composition may be used to affect super saturation conditions, e.g., through addition of a miscible non solvent.
- a process/method is provided that employs a solvent/anti- solvent crystallization technique in conjunction with the disclosed apparatus/system to produce advantageous drug nanosuspensions. As compared to micro-mixing models reported in the literature, turbulent energy dissipation rates attainable in the disclosed reaction
- chambers/microreactors are on the order of 10 7 W/kg and higher.
- the disclosed apparatus/system thus achieves rapid micro-mixing (time scale 4 ps) and meso-mixing (time scale 20 ps), with a nominal residence time in the reaction chamber that is on the order of 1 ms.
- mixing at the nanometer scale provides a uniform supersaturation ratio which is a major controlling factor in crystal formation and growth. Controlling the timing and location of the mixing of the solvent and anti-solvent streams provides control of the onset of the nucleation process. This control, in combination with a homogeneous supersaturation ratio, results in desirably uniform crystal growth and stabilization rates.
- process implementations benefit, at least in part, based on an ability to maximize the degree to which input energy is desirably directed to
- Turbulence and surface tension forces achieved according to the present disclosure are advantageously effective in initiating nano-scale events, such as formation of stable nano-emulsions and formation of sufficient molecular clustering to create/establish homogeneous nucleation sites for crystal growth.
- Exemplary applications/implementations of the present disclosure also include, but are not limited to, selectivity enhancement in competitive reaction networks, control of size of dispersed solids (whether from reactive precipitation, crystallization and/or declustering), control of crystalline drug polymorph selectivity, and formation of chaperone systems via encapsulation of active ingredients.
- the foregoing phenomena are important parameters for reactions/sy stems that are limited and/or controlled by mass transfer rates/performance.
- the present disclosure advantageously facilitates formation of critical sized clusters that become homogeneous nucleation sites for crystal growth via high degrees of local super-saturation.
- Such nucleation sites influence the molecular diffusion processes forming surfaces, their growth rates, integration of various molecular species into the surface, and ultimate size and purity of the particles formed.
- the foregoing molecular species may form various polymorphs, and the desired form can be obtained through manipulation of operational parameters, e.g., microreactor design, microreactor geometry, pressure generated by the high pressure pump, supersaturation ratio, solvents, antisolvents, temperature and combinations thereof.
- Mass transfer limitations in multiphase reacting systems can be overcome according to the present disclosure, e.g., in the production of biodiesel, because the liquid reactants have limited solubility in each other and, therefore, an interfacial reaction must occur during an initial“lag phase.”
- the rate of such interfacial reaction may be enhanced by dispersing small droplets of one phase into the other, greatly improving the interfacial surface area to volume ratio.
- Chaperone systems such as with immiscible fluids or isolation requirements from the continuous phase (as in targeting for imaging and/or drug delivery) are readily prepared via the present disclosure using surface active agents as the encapsulate and, due to minimization of potential heat effects while processing vesicles, heat liable surface active agents, such as those with protein functionality, can be utilized.
- the high shear forces associated with the disclosed reaction chambers can be beneficial when shear thinning or thickening behavior is to be exploited during processing.
- the present disclosure facilitates encapsulation down to the nano-scale of hydrophobic substances within amphi-morphic surfactants for dispersion in hydrophilic environments (or vice versa), as in nutraceutics, pharmaceutics, and cosmetics, among others.
- the encapsulates can also be useful in functionalizing membranes and providing“smart” characteristics; for example, as (a) sequestering agents in guard systems, (b) controlled release of growth factors in tissue engineering applications, (c) soluble gas transport enhancement, and (d) in general sensor/recorder systems.
- the disclosed apparatus/sy stems and methods may be used to facilitate both fast and slow processes, and to facilitate chemical reactions and physical processes, such as crystallization.
- the present disclosures advantageously facilitates production of polymer nanosuspensions in the range of 50-500 nm using both emulsion and precipitation methods.
- nanosuspensions with various polymer sizes and densities may be created.
- the disclosed systems/methods may be used to provide active pharmaceutical ingredients (APIs) that are encapsulated or otherwise contained within a polymeric matrix.
- APIs active pharmaceutical ingredients
- the polymeric matrix functions as a“chaperone” for such API’s.
- the polymeric matrix is generally amorphous and may advantageously define a biocompatible and/or bioabsorbable product.
- the feedstream for such processing techniques may include monomeric constituents, polymeric constituents or combinations thereof.
- Exemplary processing roadmaps for processing regimens may be developed using the disclosed apparatus/sy stems.
- roadmaps for drug crystallization may be developed as follows: (i) determine solvent, antisolvent and surfactant constituents based on applicable input criteria, e.g., solubilities, toxicities, compatibility and screening experiments; (ii) introduce the selected solvent, antisolvent and surfactant constituents to the disclosed
- apparatus/sy stem to produce advantageous nanosuspensions based on applicable process variables, e.g., microreactor chamber design, pressure and supersaturation ratio; and (iii) purify the nanosuspension (if required) to recover crystallized drug, e.g., using centrifuge, filter, rinsing and/or lypholization techniques.
- process variables e.g., microreactor chamber design, pressure and supersaturation ratio
- purify the nanosuspension if required
- crystallized drug e.g., using centrifuge, filter, rinsing and/or lypholization techniques.
- the disclosed roadmaps may be used to yield crystallized particles characterized by desired particle sizes and particle size distributions.
- Exemplary methods may involve, inter alia:
- the present disclosure provides other advantages compared to other approaches in the art that have been utilized.
- One advantage of the apparatus, systems and methods according to some embodiments is that such apparatus, systems and methods yield high accuracy of the desired flow rates of each stream and the flow rate ratio of the two streams combined with the ability to adjust the flow rates and the flow rate ratio of the two streams in real time, which results in a micro- or nano- particle having the desired formulation.
- An advantage according to another embodiment is the ability to vary the residence times and therefore the interaction time of the two streams at will, which makes the system suitable for processes that require long interaction (tens of seconds) and for processes that required shorter interactions (fewer than ten seconds).
- An advantage according to another embodiment is that homogenous material entering the microreactor results in processes taking place under uniform conditions. Therefore, the final product is uniform in terms of particle size, particle composition, and structure. All of the advantages described in the present disclosure improve the ability to scale up the process, while maintaining the desired flow rates, flow rate ratios, and uniform conditions in the production of the final product.
- FIG. 1 shows a system for continuously processing at least two liquid feed
- FIG. 2 shows a system for continuously processing at least two liquid feed
- FIG. 3 shows a system for continuously processing at least two liquid feed
- FIG. 4 shows an in-line mixer in accordance with an embodiment of the present disclosure
- FIG. 5 shows an in-line mixer in accordance with an embodiment of the present disclosure
- FIG. 6 shows a system for continuously processing at least two liquid feed
- FIG. 7 shows a microreactor in accordance with an embodiment of the present disclosure
- FIG. 8 shows a system for continuously processing at least two liquid feed
- FIG. 9 shows a system for continuously processing at least two liquid feed
- the present disclosure provides advantageous systems and methods for achieving effective contact/interaction of constituents within a defined chamber, i.e., a microreactor, to enhance and/or promote a host of mixing and/or reaction phenomena.
- a defined chamber i.e., a microreactor
- Set forth herein below are descriptions of exemplary system designs and implementations, including exemplary implementations and beneficial results achieved thereby.
- System 100 includes holding tank 102 and holding tank 104.
- holding tank 102 and holding tank 104 are optional equipment.
- Holding tank 102 is adapted to hold a first liquid stream 130.
- Holding tank 104 is adapted to hold a second liquid stream 132.
- Holding tank 102 is connected to a pump 106 via a first feed line 108.
- pump 106 is a metering pump, positive displacement pump, syringe pump, peristaltic pump, or piston pump.
- Pump 106 is connected to a first port 110 of an in-line mixer 112 via the first feed line 108.
- Holding tank 104 is connected to a second port 114 of an in-line mixer 112 via a second feed line 116.
- In-line mixer 112 includes first port 110 and second port 114. In-line mixer 112 also includes mixing elements 118. In some embodiments, the in-line mixer is a T-mixer, a static mixer with baffles, a rotor-stator mixer, a propeller mixer, a co-axial orifice or an ultrasonic mixer, to name a few. Such in-line mixers have a variety of energy levels and mixing intensity. In-line mixer 112 is connected to a high pressure pump (not shown) via a conduit 122. High pressure pump (not shown) is connected to a microreactor 120 via a conduit 122.
- Microreactor 120 is connected to a heat exchange unit 124 via conduit 126.
- Heat exchange unit 124 is connected to a collection tank 128 via conduit 126.
- the heat exchange unit 124 is optional equipment.
- the microreactor 120 includes a heat exchange unit (not shown), and, in such embodiments, the heat exchange unit 120 would be unnecessary.
- pump 106 is capable of pumping first liquid
- the pumping moves a precise volume of first liquid stream 130 in a specified time period providing an accurate volumetric flow rate.
- pump 106 is utilized to pump first liquid stream 130 downstream to in-line mixer 112 at an actively automatically controlled rate.
- the actively automatically controlled rate is achieved based on operation of the individually controlled pump 106.
- Second liquid stream 132 flows downstream through the second port 114 via second feed line 116.
- the flow rate of the second liquid stream 132 is controlled indirectly by the pumping action of the microreactor 120.
- the first liquid stream 130 and the second liquid stream 132 may take various forms and exhibit various properties according to the present disclosure.
- the first liquid stream 130 and the second liquid stream 132 may be multiphase fluids, miscible fluids, or immiscible fluids. In some embodiments, the first liquid stream 130 and the second liquid stream 132 may contain particles and or may contain constituents that react with each other. In some embodiments, the manner in which the first liquid stream 130 and the second liquid stream 132 are processed and/or stored prior to introduction to system 100 may vary widely, with the disclosed reservoirs and feed lines being merely illustrative of pre-processing handling/storage of reactant/fluid streams. In some embodiments, a pump (not shown) is used to deliver the second liquid stream 132 downstream through the second port 114.
- First liquid stream 130 and second liquid stream 132 each have a pre-determined flow rate and composition.
- the pump 106 is used to adjust the flow rate of the first liquid stream 130.
- a valve or orifice (not shown) is used to adjust the flow rate of first liquid stream 130 and/or second liquid stream 132.
- First liquid stream 130 and second liquid stream 132 mix in the in-line mixer 112 to form a substantially homogeneous mixture 134.
- substantially homogeneous mixture means a mixture of two liquid streams that has the same or substantially similar proportion of its constituents throughout any given sample of the mixture. For example, when dividing the volume of a mixture of two liquid streams in half, the same or substantially similar amount of constituents are present in each half.
- the composition of the constituents in the mixture of the two liquid streams may fluctuate slightly above or below the average composition of the constituents in the mixture.
- the in-line mixer 112 does not provide high enough energy to create
- nanoparticles 136 however, the microreactor 120 is employed to create nanoparticles 136.
- the substantially homogenous mixture 134 is processed by the microreactor 120 since the microreactor 120 generates turbulent flow fields that have turbulent eddies as low as 20 nm.
- first liquid stream 130 and second liquid stream 132 contain species that react with each other, chemical reactions may take place inside these eddies resulting in nanometer size particles. If the first liquid stream 130 and second liquid stream 132 are immiscible, one of the liquid streams 130 or 132 may form nanosized droplets that are dispersed in the other liquid. If surfactants are used, the droplets may be stabilized forming nanoemulsions with a long shelf life.
- in-line mixer 112 is replaced with a tube (not shown) of sufficient length inside which the first liquid stream 130 and the second liquid stream 132 may mix to form a substantially homogenous mixture 134.
- the mixing is the result of molecular diffusion and/or turbulence.
- the time required for complete mixing may be calculated as a result of velocities in the tube, the type of flow in the tube (turbulent or laminar, single phase or multiphase), the dimensions of the tube, the diffusivity of the species and other physical properties, as well the pressure and temperature.
- the substantially homogeneous mixture 134 is pumped downstream from the in-line mixer 112 to the high pressure pump (not shown) via conduit 122.
- the high pressure pump is generally effective to pressurize the substantially homogenous mixture 134 to an elevated pressure, e.g., a pressure of up to 40,000 psi.
- the term“high pressure pump” refers to a high pressure pump that is adapted to deliver high pressure output streams, e.g., 500 to 40,000 psi and higher.
- the high pressure pump is an intensifier pump or a piston.
- An exemplary high pressure pump according to an embodiment includes a hydraulic pump and a piston that multiplies the system pressure therewithin.
- the hydraulic pump may be effective to generate pressures of about 1500 to 3500 psi, and the piston mechanism may be effective to multiply such pressure by a factor of 10 c to 30
- Each piston within a pressure assembly may be viewed as a distinct high pressure pump for purposes of the present disclosure.
- Exemplary high pressure pumps according to some embodiments of the present disclosure avoid cavitation, thereby minimizing potential energy dissipation associated therewith.
- the substantially homogeneous mixture 134 is pumped downstream from the high pressure pump (not shown) to the microreactor 120 via conduit 122.
- the pumping action of the microreactor 120 pulls the second liquid stream 132 into the in-line mixer 112 (i.e., causes the flow of the second liquid stream 132 into the in-line mixer 112).
- the microreactor 120 includes a pump (not shown) that maintains a certain pressure at a port (not shown) of the microreactor 120.
- the microreactor 120 is any commercial high pressure homogenizer, including, without limitation, with fixed geometry such as Microfluidics
- valve homogenizers such as Niro Soavi (Parma, Italy), APV (PPXFLOW/ United
- High-pressure homogenizers are high energy level mixing devices and are, therefore, capable of producing nanoparticles.
- microreactor 120 produces nanoparticles 136.
- the various homogenizers have different characteristics that make them suitable or unsuitable for different applications.
- the nanoparticles 136 flow from the microreactor 120 to the heat exchange unit
- the heat exchange unit 124 is utilized to cool the nanoparticles 136.
- Nanoparticles 136 flow from heat exchange unit 124 to the collection tank 128 via conduit 126. Mixing highly affects the rates of phenomena that are responsible for forming the nanoparticles 136, including precipitation, crystallization, emulsification, or chemical reactions. These processes should be completed at the exit of the microreactor 120. If such processes are not completed at the exit of the microreactor 120, the nanoparticles 136 will continue to grow uncontrollably after the microreactor 120.
- the first liquid stream 130 and second liquid stream 132 should have sufficient contact time prior to being processed within the microreactor 120, which is facilitated by controlling the homogeneity of the mixture of the two liquid streams 130 and 132 via the in-line mixer 112 and the dimensions of the conduit 122 between the in-line mixer 112 and the microreactor 120.
- the pump 106 in combination with the high
- In-line mixer 112 is connected to conduit 122.
- Conduit 122 connects to conduit 204.
- Conduit 204 connects to overflow tank 202.
- overflow tank 202 may optionally be located before and/or after the in-line mixer 112.
- the overflow tank 202 is employed to ensure that both the in-line mixer 112 and the microreactor 120 operate at capacity.
- some amount of substantially homogeneous mixture 134 flows into overflow tank 202 from conduit 122 via conduit 204.
- FIG. 3 an illustrative system 300 for continuously processing at least two liquid feed streams in accordance with the present disclosure is schematically depicted.
- Pump 106 is connected to first port 110 of an in-line mixer 112 via first feed line 108.
- a check valve 302 is positioned on first feed line 108 between pump 106 and in-line mixer 112.
- Second feed line 116 is connected to second port 114 of in-line mixer 112.
- a check valve 304 is positioned on the second feed line 116 before the second port 114 of in-line mixer 112.
- In-line mixer 112 is connected to microreactor 120 via a conduit 122.
- a check valve 306 is positioned on conduit 122 between in-line mixer 112 and microreactor 120.
- Check valves 302, 304, and 306 are used to prevent backflow of the first liquid stream 130, the second liquid stream 132, and/or the substantially homogeneous mixture 134. In some embodiments, check valves 302, 304, and 306 are optional equipment.
- the in-line mixer 400 includes baffles 402.
- the baffles 402 are employed in the in-line mixer 400 to increase the contact area for interaction between the first liquid stream 130 and the second liquid stream 132.
- the baffles 402 are utilized to achieve desired hydrodynamic profiles, stress levels, and heat transfer as required by the system of the present disclosure.
- In-line mixer 500 is a T-mixer.
- First liquid stream 130 is pumped to first port 110 of the in-line mixer 500.
- Second liquid stream 132 flows to second port 114 of the in-line mixer 500.
- the first liquid stream 130 and second liquid stream 132 enter the in-line mixer 500 via the first port 110 and second port 114, respectively.
- In-line mixer 500 mixes the first liquid stream 130 and the second liquid stream 132 to form a substantially homogeneous mixture 134.
- FIG. 6 an illustrative system 600 for continuously processing at least two liquid feed streams in accordance with the present disclosure is schematically depicted.
- Pump 106 is connected to a first port 606 of a co-axial orifice 602 via the first feed line 108.
- the co-axial orifice 602 includes a first co-axial tube 610 and a second co-axial tube 612.
- the second feed line 116 is connected to a second port 608 of the co-axial orifice 602.
- First co-axial tube 610 and second co-axial tube 612 connects to third port 614 of the in-line mixer 604.
- In line mixer 604 includes third port 614.
- First liquid stream 130 is pumped to first port 606 of a co-axial orifice 602 via first feed line 108.
- Second liquid stream 132 flows to second port 608 of the co-axial orifice 602 via second feed line 116.
- the first liquid stream 130 and second liquid stream 132 enter the co- axial orifice 602 via the first port 606 and second port 608, respectively.
- the first liquid stream 130 enters first co-axial tube 610
- the second liquid stream 132 enters the second co-axial tube 612. While in the first co-axial tube 610 and second co-axial tube 612, first liquid stream 130 and second liquid stream 132, respectively, are flowing separately from each other.
- in-line mixer 604 mixes the first liquid stream 130 and the second liquid stream 132 to form a substantially homogeneous mixture 134.
- in line mixer 604 has lower energy levels by orders of magnitude.
- present disclosure may be controlled by a control system that includes a controller having one or more processors and one or more memory devices.
- the one or more memory devices may include instructions stored therein that are executable by the one or more processors to control various functions and activities performed by the systems of the present disclosure.
- the microreactor 700 includes a pumping mechanism that generates high pressures, in the thousands or tens of thousands of psi.
- the term“microreactor” is synonymous with“reaction chamber,”“interaction chamber,” and“processing module.”
- the microreactor 700 also includes a processing module that contains passages with small dimensions, typically 10-5000 microns.
- pumping systems that may be utilized in microreactor 700, differing in the design and principal of operation.
- the geometry of the microreactor 700 may take various forms to effect the desired shear field and/or shear force.
- the microreactor 700 may be characterized by (i) a “Z” or“L” type single slot geometry, (ii) a“ Y” or“T” type single slot geometry, (iii) a“Z” or “L” type multi-slot geometry; or (iv) a“Y” or“T” type multi-slot geometry.
- the terms“Z” type and“Y” type refer to Microfluidics’ reaction chamber geometries.
- the terms“L” type and“T” type refer to DyHydromatics’ (Maynard, MA) reaction chamber geometries.
- Each of the foregoing microreactor geometries is known in the art and is generally adapted to provide a high shear field for interaction between the reactants/constituents introduced thereto.
- the terms“Z” type and“Y” type refer to Microfluidics’ reaction chamber geometries.
- the terms“L” type and“T” type refer to DyHydromatics’
- microreactor 700 has an internal volume that is on the scale of a microliter, and average velocities in the microchannels may reach and/or exceed 500 m/s. Changes in velocity magnitude and/or direction associated with the microreactor 700 yields substantially uniform, high shear fields. The high turbulence achieved in the disclosed reaction chambers/microreactors advantageously facilitates mixing/contact at the nanometer level.
- the disclosed microreactor 700 is generally effective to generate nanoscale mixing, tight particle size distributions, and high levels of repeatability/scalability.
- valve homogenizers particle size and narrower particle size distribution than the size of material produced with valve homogenizers.
- contact times of fluids in valve homogenizers are generally shorter than those in fixed geometry homogenizers. Therefore, relatively fast processing may benefit from valve homogenizers in addition to minimizing the dimensions of the conduit between the in-line mixer and the homogenizer. The reason for this difference is the different pumping mechanism to produce high pressure that these homogenizers use.
- the fixed geometry homogenizers typically use constant pressure pumping mechanisms.
- nanoparticles with desired properties including, without limitation:
- the particle size of the substantially homogenous mixture depends on the turbulent energy dissipation rate (turbulent mixing intensity) of the in-line mixer.
- Each type of mixer has its own intrinsic rate, which may be further controlled by adjusting the operational parameters of the in-line mixer.
- operational parameters include the geometry of the in-line mixer and the flow rates of the individual liquid streams.
- the geometry of the conduit between the in-line mixer and the microreactor affects the contact time of the liquid streams. Slow processes require longer times and therefore longer conduits than faster processes.
- the internal geometries of the in-line mixer and microreactor also affect the contact times.
- the microreactor highly influences the final particle size through (i) the pressure, which is a measure of the energy imparted on the fluid, and (ii) the geometry of the processing module of the microreactor.
- the processing module of the microreactor has various names, depending on the type of the device and the manufacturer. For example, in valve homogenizers the processing module is named a homogenizing valve. Microfluidics names its processing modules interaction chambers while DyHydromatics names their processing modules reaction chambers. Another name commonly used to describe the processing module is a microreactor.
- the temperature of the fluids throughout the system influences the final product.
- methods of the present disclosure include nanoemulsions, nanodispersions, liposomes (semi- solids), lipid nanoparticles (semi-solids), crystalline or amorphous materials, complex particles with ingredients embedded in a solid, semi-solid or liquid matrix, complex particles with ingredients encapsulated by solid, semi-solid or liquid materials, polymer particles, and high purity chemicals (not necessarily containing particles), to name a few.
- Such materials are generally produced by creating two liquid phases and mixing the phases together.
- the phases are miscible.
- the phases are immiscible.
- the phases are referred to as the“oil phase” and the“water phase.”
- the oil phase may contain an oil phase constituent selected from vegetable oil (including, without limitation, soybean oil, olive oil, palm oil, corn oil, canola oil, sesame oil, rice oil, refined vegetable oils, oils rich in omega-3 fatty acids, and algal oil), nut oils, animal oils (including, without limitation, fish oil), inorganic oils (including, without limitation, mineral oil, perfluorocarbon oils including, without limitation, FC43, and
- lipids including, without limitation, egg phospholipids, lecithin,
- phosphatidylcholine cholesterol, Palmitoyl oleoyl phosphatidylcholine, cationic lipids, and anionic lipids
- modified or functionalized lipids Hydrophilic phosphatidyl choline from soybean lecithin, N-(Methylpolyoxy ethylene oxycarbonyl)-l,2-distearoyl-sn-glycero-3- phosphoethanolamine, and sodium salt (DSPE-PEG), waxes (including, without limitation, beeswax, and paraffin wax), surfactants (including, without limitation, Tween®, Span®, poloxamers such as 188, Solutol® such as polyethylene glycol (l5)-hydroxystearate, block co polymers), polymers (including, without limitation, poly lactic acid (PLA), poly lactide-co- glycolide (PLGA), poly-epsilon-caprolactone, poly styrene, acrylics such
- the water phase may contain a water phase constituent selected from water, lipids (including, without limitation, egg phospholipids, lecithin, phosphatidylcholine, cholesterol, Palmitoyl oleoyl phosphatidylcholine, sterols, neutral lipids, cationic lipids, and anionic lipids), modified or functionalized lipids (including, without limitation, hydrogenated phosphatidyl choline from soybean lecithin, N-(Methylpolyoxyethylene oxy carbonyl)- l,2-distearoyl-sn-glycero-3-phosphoethanolamine, and sodium salt (DSPE-PEG)), surfactants (including, without limitation, Tween®, Span®, poloxamers such as 188 and 407, Solutol® such as Polyethylene glycol (l5)-hydroxystearate, block co-polymers, polysaccharides, casein, lecithin, w
- lipids including, without
- Each of the disclosed system designs may be advantageously employed according to the present disclosure to achieve variable/desired ratios between feed streams within the downstream microreactor.
- the disclosed apparatus/system may be used in a wide range of applications
- particle size reduction applications e.g., emulsion and suspension applications
- cell disruption application e.g., e-coli and yeast applications
- reaction applications e.g., crystallization applications
- crystallization processes include crystallization processes, precipitation processes, emulsion formation processes, particle coating processes, and particle mixing processes.
- the foregoing processes generally benefit from molecular interaction at the nanometer scale.
- Each of these processes can be undertaken using the disclosed apparatus/sy stems according to different methods and/or roadmaps (i.e., processing of specific constituents under specific process parameters to achieve specific results), as will be readily apparent to persons skilled in the art.
- processing a solvent and antisolvent stream (and optionally a surfactant) with the disclosed apparatus/sy stem may lead to crystallization or precipitation of the solute dissolved in the solvent stream.
- changing the pH of a solution by mixing the initial solution with a stream that changes the pH of the final solution may result in crystallization and/or precipitation of the solute.
- emulsions may be formed by direct and continuous interaction of continuous and dispersed phases, e.g., an oil stream with an aqueous/water stream.
- stable emulsions and nano-emulsions are formed in two steps. Initially, a coarse pre-emulsion is made by mixing the immiscible liquids with conventional mixing equipment, such as a propeller or a rotor/stator mixer. Subsequently, in some embodiments, the coarse emulsion may be processed using a standard MICROFLETDIZER® processor (Microfluidics Corp., Newton, Mass.) or a high shear homogenizer. However, with the disclosed apparatus/sy stem, the step of producing pre-emulsions may be advantageously avoided.
- Coatings can thus be formed by physical or chemical adsorption of the coating material onto the particle surface.
- reaction chamber/microreactor advantageously increases the interaction surface area among the reactant streams to a significant degree, thereby minimizing potential diffusion limitations and increasing reaction rates.
- Undesirable side reactions and/or slow reactions can be minimized by creating conditions within the disclosed reaction chamber/microreactor, wherein the conditions are analogous to a“well stirred reactor”. Indeed, the disclosed apparatus/sy stems may be effective in avoiding reactions that are a result of concentration gradients.
- apparatus/sy stems include, without limitation, acid-base reactions, ion exchange processes, reduction/oxidation reactions, polymerization reactions, precipitation reactions, substitution reactions, crosslinking reactions, reactive crystallization reactions, biodiesel reactions, and the like. More particularly, the following exemplary application/implementation categories may benefit from processing with the disclosed apparatus/system: (i) production of nanoparticles via crystallization, precipitation or chemical reactions; (ii) coating of particles; (iii) mixing of heterogeneous materials at the nanometer scale; (iv) expediting chemical reactions, and (v) Process Intensification
- Time scales for the macro-, meso-, and micro-mixing processes may thus be estimated and, along with the length scales, prediction of operational roadmaps may be undertaken that correlate well with transport rates, particle size observations, and well established theoretical approaches.
- Such testing permits enhancement of system performance, such that the disclosed apparatus, systems and methods may be effectively and advantageously used, inter alia, to measure millisecond kinetics, conduct micro-scale reactions, facilitate formation of nano-emulsions/suspensions via turbulent mixing, and achieve enhanced mass transfer operations needed for controlled nucleation and growth in precipitation and crystallization, e.g., for protein and inorganic substances.
- reaction chamber residence times from 0.5-1 ms
- nano-emulsion droplet and particle diameters in the range 25-500 nm are nano-emulsion droplet and particle diameters in the range 25-500 nm:
- process intensification facilitates integration of
- PI strategies based on the present disclosure provides numerous benefits. Exemplary advantageous outcomes that may be realized through adaptation of the disclosed PI strategies include:
- Safety benefits which translate to, inter alia, decreased volumes of explosive, hazardous or toxic compounds, enhanced operator friendliness, and potential isolation in secondary containment chambers, as desired.
- the apparatus/systems and methods of the present disclosure facilitate improved reactor performance.
- the disclosed reactors can provide a number of key advantages by, for example, cutting residence times, accelerating reaction rate, minimizing side reactions and/or reducing energy intensive downstream processing steps, such as distillation and extraction.
- energy intensive downstream processing steps such as distillation and extraction.
- heat and mass transfer limitations which are determined by the contacting patterns obtained via the intensity of mixing (i.e., the hydrodynamics). These heat/mass transfer limitations can thus control the observed system dynamics, rather than fundamental kinetics of the reaction system.
- reaction rate of a particular system there are several ways that apparent reaction rate of a particular system can be increased according to the present disclosure.
- mass transfer limitations that are common to heterogeneous reactions may be removed by increasing the surface area-to-volume ratio of the dispersed phase. Once the mass transfer limitations are removed (or substantially reduced), the reaction may
- enhanced identification and/or control of the temperature profile throughout the reactor may be achieved, which generally leads to better control of the reaction rate.
- a highly exothermic reaction carried out in a large batch vessel may require several hours, not because of any inherent kinetics constraint but because of the time necessary to remove the heat of reaction safely via its poor transfer area-to-volume ratio using a traditional coil configuration.
- intense mixing and improved heat transfer mechanisms associated with the low holdup of material in the reactor better productivity is possible according to the present disclosure. As a result of these enhanced transport
- Process data connected with computational fluid dynamics (CFD) modeling, may advantageously provide a basis for design, redesign and/or reconfiguration of system designs and layouts.
- CFD can also be used to predict: (1) velocity and stress distribution maps in complex reactor performance studies; (2) transport properties for non-ideal interfaces; and (3) materials processing capabilities useful in encapsulation technology and designing functional surfaces, especially where self-assembly mechanisms, surface tension and interfacial forces, and turbulent energy driven processes dominate.
- the primary objectives for both precipitation and crystallization processes are to (1) increase concentration, e.g., when precipitating from a dilute solution, and/or (2) purify a material, such as when selectively crystallizing one species from a solution containing multiple types.
- Each process is generally initiated by changes in the thermodynamic state of the solution, thereby reducing the solubility of the target species. Initiation may thus be undertaken via temperature adjustment(s), concentration adjustment(s), e.g., by addition of antisolvents, or adjustment of solution activity coefficients, e.g., by addition of ionic species.
- processing approaches may include: (1) pH adjustment to the isoelectric point, (2) addition of organic solvents, (3) increasing ionic strength to cause salting out, and/or (4) addition of non-ionic polymers.
- Nucleation sites must be created to initiate precipitation and/or crystallization processes, either by generating a very high super-saturation resulting in spontaneous growth (homogeneous nucleation) or seeding the solution with surfaces for growth (heterogeneous nucleation), whether inert or the desired target species. In all cases, it is essential that the solubility of the target species be reduced below the actual concentration in solution. This effectively creates a concentration in excess of the thermodynamic equilibrium saturation value and rate processes then dominate system behavior. The magnitude of the difference from equilibrium, i.e., degree of super-saturation, influences both type and rate of system response.
- homogeneity is generally dependent on diffusivity of the target species and distance the target species molecules must travel within the mixing eddies (i.e., Kolmogorov length), which can be estimated using turbulence theory. Calculation/analysis requires knowledge of the mixing power input and subsequent energy dissipation rate per unit volume along with solution properties such as density and viscosity.
- nucleation of small solid particles occurs.
- the nucleation rate increases exponentially with respect to super-saturation up to a characteristic limiting rate, and the features of the product formed depend significantly on this rate. If the nucleation rate is too high, the result is likely to be a colloid (i.e., highly solvated) and, thus, complicated downstream processing may be required.
- Growth rate is determined by diffusion of solute molecules from the bulk solution to the solid surface and/or a surface integration rate, until a limiting particle size is reached.
- the limiting particle size is generally determined by the magnitude of shear in the mixed solution.
- the crystallization process begins by reducing the solubility of the target species.
- relatively low degrees of super-saturation are utilized since, at high levels, the solids formed tend to be an amorphous precipitate (rather than crystalline).
- Control of the rate processes is essential to directing the path to a desired final thermodynamic state and to achieving a desired morphology.
- Spontaneous formation of solids can entrap undesired species into the lattice framework.
- slowing the growth rate by reducing/lowering the super-saturation level permits higher selectivity in the surface integration mechanism, i.e., crystals are formed that are very pure due to exclusion of other contaminate species. Locally high shear forces can also help maintain appropriate/desirable transport gradients. Crystallization may thus be used as a primary separation method and/or as a finishing step to yield product of desired purity according to the present disclosure.
- nanoscale particles and/or emulsions that encapsulate active ingredients has applicability in many facets of the engineering biosciences.
- nano- technologies are having a major impact on drug delivery, molecular targeting, medical imaging and biosensor development, as well as on cosmetic and personal care products, and nutraceutics.
- conventional mixing equipment in which a high shear, elongated flow field is generated near the tip of high-speed blade(s) only generate emulsions with droplet sizes in the range 500 nm and larger. Such emulsions are stable only if sufficient surface active agents are present to control agglomeration and re-growth.
- This approach to emulsion stability requires proper distribution of the surfactant for the appropriate surface coverage of the droplets, thereby minimizing Oswalt ripening and subsequent undesired size distribution changes.
- the higher shear rates achieved according to the present disclosure advantageously facilitate generation of stable mean particle sizes in the range 50 to 100 nm and requisite/desired narrow particle size distributions.
- the disclosed systems/techniques may also advantageously dispense with the need for surfactants for stability, dependent upon the surface characteristics of the emulsion constituents and their intended applications.
- jet impingement on a solid surface e.g. Z-type microreactor
- another jet e.g., Y-type microreactor
- Systems that incorporate high velocity linear fluid jets that collide can rapidly reduce the scale of segregation between the streams.
- These jets can be considered as free, submerged, or confined.
- a free jet stream is not affected by the walls of a surrounding chamber/vessel nor any surrounding fluid, in contrast to submerged jets where viscous drag forces may be significant.
- the dimensions of the chamber/vessel relative to jet diameter can play a major role in system performance.
- microreactors of the present disclosure may be quantified using computational fluid dynamics (CFD) techniques and has been calculated to be on the order of seven (7) to ten (10) jet diameters for the radial dimension of the impingement plane.
- CFD computational fluid dynamics
- the other cylinder dimension (height) has been shown to be independent of jet diameter and the design thereof is typically related to the inter-penetration length of the two jets.
- the height dimension is calculated to be about 10 percent of the inter-nozzle (jet separation) distance.
- Interfacial mass transfer area may be used to characterize mixing quality and to quantify associated length scales. Using known transfer areas, diffusion lengths, and physico chemical properties of fluids that permit measurement of appropriate rate phenomena to determine transport parameters, it is possible to determine an interfacial transfer coefficient, mass diffusivity, and a system characteristic time constant. Connecting these fundamental parameters with system geometric configurations, operating variables and measured performance metrics (such as quantity transported and approach to equilibrium, if not obtained), it is possible to determine transfer areas that must necessarily be present in an reaction chamber/microreactor. In addition, from this interfacial area, it is possible to identify the eddy size scale (i.e.,
- process innovations are disclosed herein that (i) utilize flow instabilities for mixing, (ii) improve contacting patterns to enhance interactions that promote better kinetics performance and transport rates, and (iii) improve transport via mechanical turbulence promoters. DESCRIPTION OF PROCESS AND CONTROLS FOR A METHOD FOR
- This step generally starts with the desired formulation of the final product at each stage of processing.
- the examples below show how to set up the system of the present disclosure to create an emulsion from two immiscible liquid streams. This similar procedure is used when mixing miscible liquid streams for the purpose of conducting crystallization, precipitation, and chemical reactions, among others.
- Option 1 an oil/water emulsion in which the oil phase is 5% by volume and the water phase is 95% by volume is created.
- Option 2 The desired formulation of the final product may be different than the formulation at intermediate stages.
- the oil phase is delivered in two steps. For example, in the first step, half of the oil is delivered to the water phase to create an emulsion with 2.5% by volume oil. In the second step, this first emulsion becomes one of the streams, while the other stream consists the remainder of the oil.
- Option 3 It is possible that a concentrated emulsion is homogenized. After
- the concentrated emulsion may be diluted further with addition of the continuous (water) phase or parts of the water phase.
- Option 2 it may be possible to homogenize an emulsion containing 10 vol% oil without sacrificing the particle size. This emulsion is then diluted with the addition of the water phase or pure water such that the final concentration of the oil phase in the emulsion is 5 vol %.
- the flow rate of each stream is calculated as follows. [0117] The total flow rate of the system of the present disclosure is measured at the outlet of the homogenizer. Subsequently, each of the metering pumps is set to provide the appropriate flow rate based on the desired volume fraction of the particular stream in the final formulation. The total flow rate of the homogenizer is measured under set conditions of pressure, hardware, type of in-line mixer upstream, and temperature when a single stream of the material is processed. The flow rate of each of the streams is calculated by multiplying the total flow rate with the percentage of that stream in the formulation, the final or intermediate, based on the specific formulation.
- the oil metering pump (if present) should be set at 15 ml/min (5% of 300 ml/min) while the water metering pump (if present) should be set at 285 ml/min (85% of 300 ml/min).
- the flow rate of the input streams not having a dedicated metering pump may be controlled indirectly by the pumping action of the homogenizer.
- the accuracy of the calibration may be optionally verified by conducting
- Priming is completed to remove air from the system of the present disclosure, which, in some embodiments, includes the metering pump(s), the in-line mixer, the feed pump(s), the homogenizer, and the lines connecting those. Priming is accomplished by passing a liquid through the system generally at a low pressure. Optionally, priming is sometimes completed using the stream with the highest flow rate or the stream with constituents that are readily available or inexpensive. 2.2 Processing
- the pressure is set to the desired value and the pump of the second stream is turned on.
- the initial volume equal to the holdup volume of the machine is discarded because it does not contain ingredients from the second stream.
- the homogenizer produces the material with the desired composition.
- the homogenizer Following the first pass of the liquid streams through the homogenizer, there may be several other processes depending on the outcome of the first pass.
- composition of the formulation is similar to the desired formulation but the particle size is larger than desired, the material is processed through the homogenizer a few more times, if necessary, until the desired particle size is achieved. In this case, after the first pass, a single liquid stream will be processed each time through the homogenizer.
- composition of the formulation is incorrect because, for example, only part of the one liquid stream had been incorporated in the preliminary formulation, the remaining material may be incorporated in a similar method during a second pass through the homogenizer.
- the end formulation from the first pass may constitute one of the streams in the second pass.
- Quenching is used to stop processes from continuing.
- quenching may be used to stop a chemical reaction and/or crystal growth during crystallization, to prevent oil droplets from coalescing with each other, and/or to prevent particles from agglomerating, among others.
- FIG. 8 an illustrative system 800 for continuously processing at least two liquid feed streams in accordance with the present disclosure is schematically depicted.
- a flowmeter 802 is positioned on conduit 126 in between heat exchange unit 124 and collection tank 128.
- Flowmeter 802 measures the total flow rate of the system 800.
- Direct measurements of the flow rate ratio may be conducted with the use of flowmeter 802.
- gravimetric measurements may be performed.
- Indirect measurements may be conducted by counting the stroke rate of the microreactor 120.
- the microreactor 120 is a constant pressure homogenizer, such homogenizers typically deliver a constant liquid volume per stroke.
- an electronic signal which is related to the magnitude of the flow rate (input signal) may be generated.
- output electronic signal(s) 804 may be generated by flowmeter 802 and delivered to pump 106.
- output electronic signal(s) 804 are delivered to pump 106 via electrical wiring (not shown) or wirelessly (not shown).
- Output electronic signal(s) 804 may be estimated to represent the desired flow rate of each stream.
- Output electronic signal(s) 804 are used to control the flow rate of pump 106.
- the output electronic signal(s) 804 control of pump 106 occurs in real time.
- output electronic signal(s) 804 are used to control the flow rate of valves (not shown).
- E-Stop 902 is electrically connected to microreactor 120 and pump 106.
- E-Stop 902 is electrically connected to microreactor 120 and pump 106 via electrical wiring or wirelessly.
- E-Stop 902 is electrically connected to a switch 904.
- Pump 106 and microreactor 120 are electronically connected to E-Stop 902.
- E-Stop 902 is connected to any suitable equipment used in system 900.
- the E-Stop 902 is utilized to stop all key equipment in system 900 at the same time in case of an emergency. If the microreactor 120 stops while the pump 106 is operating, it is possible that the feed lines are over pressurized or expensive material may be leaking or otherwise wasted.
- the E-Stop 902 is designed such that when the microreactor 902 stops, the E- Stop 902 forces the pump 106 to stop. Additionally, if the microreactor 120 is slowing down or speeding up due to blockage or loss of liquid streams, respectively, the pump 106 is forced to stop.
- a single E-Stop 902 is utilized for the pump 106, the
- Switch 904 is utilized in system 900 to turn off the power to any equipment that is connected to the E-Stop 902.
- the high pressure homogenizer is set to 20,000 psi and is equipped with two
- reaction chambers in series, suitable for emulsions.
- the reaction chambers are the 75.3T and the 200.2L, respectively, which are available from DyHydromatics, LLC.
- Downstream of the reaction chambers is a coil heat exchanger, which cools the processed material using water at 21 °C as a cooler.
- the equipment is preheated with hot water to 55-60 °C prior to processing the emulsion.
- the emulsion is passed three times through the homogenizer at initial temperatures 55, 37, and 30 °C at each pass, respectively.
- the emulsion is then collected and the particle size analysis is performed.
- Particle size analysis is performed using a PSA 1190 L/D Laser Diffraction
- a 6 inch in-line, static mixer (1 ⁇ 4-40-3-l2-2) is obtained from Koflo Corporation (Cary, Ill.).
- a peristaltic pump, Model BT101L-CE Version V122S121 with #15 tubing from Golander, LLC (Norcross, GA), is used to pump the oil to the homogenizer at a predetermined rate.
- the high pressure homogenizer is set to 20,000 psi and is equipped with two reaction chambers in series, suitable for emulsions.
- the reaction chambers are the 75.3T and the 200.2L, respectively, which are available from DyHydromatics, LLC. Downstream of the reaction chambers is a coil heat exchanger, which cools the processed material using water at 21 °C as a cooler.
- the homogenizer, dual feed, and all lines are preheated with hot water to 55-60 °C prior to processing.
- the initial temperatures at each pass through the homogenizer are 55, 37, and 30
- Particle size analysis is performed using a PSA 1190 L/D Laser Diffraction
- the emulsion of EXAMPLE 2 prepared using the method of the present disclosure has smaller particle size (24lnm versus 280 nm), and narrower particle size distribution as inferred by the low Polydispersivity Index (9.6% versus 17.4%).
- Examples 3 and 4 compare two different feed systems in terms of accuracy in achieving the desired ratio of the two streams and, therefore, the desired formulation.
- Propofol emulsion is an emulsion used in anesthesia worldwide. A common formulation of the propofol emulsion shown in Table 3 is prepared.
- a 400 g batch of propofol emulsion is prepared based on the formulation shown in Table 3 (second column).
- Water for Injection (WFI) is heated in a beaker on a hot plate to 45 °C.
- Egg lecithin, glycerol, and sodium oleate are added, and the mixture is stirred until all ingredients are dissolved.
- All ingredients of the oil phase are placed in a beaker and heated to 45 °C .
- the density of the oil and water phases are measured by measuring the weight of a certain volume of each phase. Based on these results, the oil phase is found to be 11.84 vol% and the water phase is found to be 88.16 wt%.
- a high pressure homogenizer HP350-30 from DyHydromatics, LLC (Maynard,
- MA ETSA is fitted with Delphi Scientific LLC’s dual feed DF-X-01.
- a 6 inch in-line, static mixer (1 ⁇ 4-40-3-l2-2) is obtained from Koflo Corporation (Cary, Ill.).
- a peristaltic pump, Model BT101L-CE Version V122S121 with #15 tubing from Golander, LLC (Norcross, GA), is used to pump the oil to the homogenizer at a predetermined rate.
- the high pressure homogenizer is set to 21,000 psi and is equipped with two reaction chambers in series, suitable for emulsions.
- the reaction chambers are the 75.3T and the 200.2L, respectively, which are available from DyHydromatics, LLC.
- Downstream of the reaction chambers is a coil heat exchanger, which cools the processed material using water at 21 °C as a cooler.
- the homogenizer, dual feed, and all lines are preheated with hot water to 45-50 °C prior to processing.
- the homogenizer, the inline mixer, and all lines are primed with water to displace the air. Subsequently, the water phase is poured into the reservoir of the homogenizer, while the oil phase is poured into a beaker.
- the inlet tubing of the peristaltic pump is dipped inside the oil phase and the outlet is connected to one of the ports of the inline mixer. The homogenizer and the peristaltic pump are started. The processed emulsion is collected from the outlet of the homogenizer.
- the concentration of oil in the emulsion is calculated to be 11.16 wt%, which corresponds to 1.45% higher oil concentration (and therefore drug concentration) of the formulation when compared to the desired 11 wt% oil. These results are within the acceptable range, which is usually +1-2% from an average value. Additionally, if desired the emulsion may be slightly diluted to achieve the desired 11%.
- Example 4 The formulation of Example 3 shown in Table 3 is used in Example 4.
- a 400 g batch of the propofol emulsion is prepared based on the formulation shown in Table 3 (second column).
- Water For Injection (WFI) is heated up in a beaker on a hot plate to 45 °C.
- Egg lecithin, glycerol, and sodium oleate are added and the mixture is stirred until all ingredients are dissolved.
- All ingredients of the oil phase are placed in a beaker and heated to 45 °C .
- the density of the oil and water phases are measured by measuring the weight of a certain volume of each phase. Based on these results, the oil phase is found to be 11.84 vol% and the water phase 88.16 wt%.
- a high pressure homogenizer, HP350-30 from DyHydromatics, LLC Maynard,
- a peristaltic pump Model BT101L-CE Version V122S121 with #15 tubing from Golander, LLC (Norcross, GA) is used to pump the water phase.
- Another peristaltic pump from LongerPump (Tucson, AZ), model UZ1515c with tubing L/S 16 from Masterflex from Cole Palmer (Vernon Hills, IL), is used to pump the oil phase.
- each pump is connected to one of the two inlets of a co-axial feed, and such feed consists of two concentric tubes and is positioned at the inlet of the homogenizer.
- feed consists of two concentric tubes and is positioned at the inlet of the homogenizer.
- Each liquid stream flows into one tube, and therefore there is no mixing of the two streams until such streams reach the inlet of the homogenizer.
- the homogenizer, the co-axial feed, and all lines are primed with water to displace the air. Subsequently, the oil and water phases are poured in two separate beakers. The inlet tubing of each peristaltic pump is dipped inside one beaker and the outlet is connected to one of the ports of the co-axial feed. The homogenizer and the peristaltic pumps are started. The processed emulsion is collected from the outlet of the homogenizer.
- EXAMPLE 4 The set point of the flow rate of the oil pump is increased by 9.34% to 47.54 ml/min (by 4.09 ml/min) while the flow rate of the water is decreased by the same amount (4.09 ml/min), which would simulate automatic control of the pump flow rates.
- the oil content is inferred, and such oil content is found to be 9.97 wt%.
- the oil content is again lower than the desirable by 9.36%, which is unacceptable in most applications.
- Norfloxacin which is a highly hydrophobic (having limited solubility in water) pharmaceutical, is selected as a model drug to demonstrate the applicability of the disclosed apparatus, systems and methods based on: (a) limited water solubility, (b) availability, and (c) price.
- Norfloxacin is recrystallized using the method of the present disclosure to obtain submicron particles. Such particles may increase the bioavailability of norfloxacin, which such bioavailability is limited by norfloxacin’s limited water solubility.
- DMSO DMSO
- Tween® 80 surfactant
- Example 2 The system described in Example 2 is used for processing.
- the total flow rate of the equipment is 403 ml/min.
- the density of the DMSO phase is determined to be 1.1 g/ml.
- the desired volume fraction of the DMSO phase compared to the total volume flow rate of the machine is 18.48%.
- the total flow rate of the peristaltic pump that delivers the DMSO phase is set to 74.48 ml/min.
- the two streams are processed once through the equipment to ensure mixing and interaction of the full amount of the DMSO phase with the water phase.
- a liquid dispersion containing white norfloxacin particles is obtained, and such dispersion is then again passed through the homogenizer. This time the port that delivered the DMSO mixture is not used and is closed.
- the dispersion is poured into the machine reservoir and is delivered to the homogenizer as a single mixture.
- the dispersion is processed again to de-agglomerate possible agglomerates formed during the first pass.
- Particle size of the material is conducted using a Litesizer Dynamic Light
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Fluid Mechanics (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA3075827A CA3075827C (en) | 2018-06-22 | 2019-06-24 | Apparatus, systems, and methods for continuous manufacturing of nanomaterials and high purity chemicals |
| EP19822688.8A EP3664785A4 (en) | 2018-06-22 | 2019-06-24 | DEVICE, SYSTEMS AND PROCESSES FOR CONTINUOUS PRODUCTION OF NANOMATERIALS AND HIGH PURITY CHEMICALS |
| JP2020570488A JP7320852B2 (ja) | 2018-06-22 | 2019-06-24 | ナノ材料及び高純度化学物質を連続製造する装置、システム、及び方法 |
| US16/624,631 US11191723B2 (en) | 2018-06-22 | 2019-06-24 | Apparatus, systems, and methods for continuous manufacturing of nanomaterials and high purity chemicals |
| IL273251A IL273251B (en) | 2018-06-22 | 2020-03-12 | Device, systems and methods for the continuous production of nano-materials and chemicals with a high degree of cleanliness |
| US17/516,174 US12036320B2 (en) | 2018-06-22 | 2021-11-01 | Apparatus, systems, and methods for continuous manufacturing of nanomaterials and high purity chemicals |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862688755P | 2018-06-22 | 2018-06-22 | |
| US62/688,755 | 2018-06-22 | ||
| US201962788298P | 2019-01-04 | 2019-01-04 | |
| US62/788,298 | 2019-01-04 |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US16/624,631 A-371-Of-International US11191723B2 (en) | 2018-06-22 | 2019-06-24 | Apparatus, systems, and methods for continuous manufacturing of nanomaterials and high purity chemicals |
| US17/516,174 Continuation US12036320B2 (en) | 2018-06-22 | 2021-11-01 | Apparatus, systems, and methods for continuous manufacturing of nanomaterials and high purity chemicals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2019246615A1 true WO2019246615A1 (en) | 2019-12-26 |
Family
ID=68983462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2019/038705 Ceased WO2019246615A1 (en) | 2018-06-22 | 2019-06-24 | Apparatus, systems, and methods for continuous manufacturing of nanomaterials and high purity chemicals |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US11191723B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3664785A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7320852B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3075827C (cg-RX-API-DMAC7.html) |
| IL (1) | IL273251B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019246615A1 (cg-RX-API-DMAC7.html) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111359540A (zh) * | 2020-04-08 | 2020-07-03 | 福州大学 | 用于微反应器的无脉动浆料进料装置及使用方法 |
| EP4582176A3 (en) * | 2021-11-03 | 2025-10-15 | leon-nanodrugs GmbH | Apparatus and method for mixing small liquid volumes, and use of the apparatus |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110290774B (zh) * | 2016-09-30 | 2022-10-14 | 株式会社爱茉莉太平洋 | 含有利用微流体通道瞬时乳化的乳化物质的化妆品组合物制备装置 |
| EP3664785A4 (en) * | 2018-06-22 | 2022-01-12 | Delphi Scientific, LLC | DEVICE, SYSTEMS AND PROCESSES FOR CONTINUOUS PRODUCTION OF NANOMATERIALS AND HIGH PURITY CHEMICALS |
| KR102252373B1 (ko) * | 2018-12-31 | 2021-05-14 | (주)아모레퍼시픽 | 화장품 제조 장치 |
| KR102941878B1 (ko) * | 2019-02-05 | 2026-03-23 | 린디 바이오사이언시스, 아이엔씨. | 단리된 세포 배양 성분 및 액체 세포 배양 배지로부터 이를 단리하는 방법 |
| EP3879360A1 (en) * | 2020-03-12 | 2021-09-15 | Basf Se | Method for controlling and/or monitoring an equipment of a chemical plant |
| CN112206695B (zh) * | 2020-09-16 | 2021-11-19 | 复旦大学 | 一种多层次结构微通道混合器及其流体混合方法 |
| EP4384306A4 (en) * | 2021-08-12 | 2025-06-25 | Academia Sinica | MICROFLUIDIC MIXER FOR IMPROVED THREE-DIMENSIONAL MIXING |
| EP4163006B8 (en) * | 2021-10-11 | 2024-03-20 | leon-nanodrugs GmbH | Methods for validating an apparatus for producing nanoparticles |
| CN113961022B (zh) * | 2021-12-21 | 2022-03-11 | 中国飞机强度研究所 | 一种飞机测试的压力控制系统及压力控制方法 |
| CN114957732B (zh) * | 2022-05-31 | 2025-08-12 | 浙江大学 | 一种基于微反应器系统的生物相容纳米团聚体颗粒制备方法 |
| CN115193496B (zh) * | 2022-07-18 | 2024-02-27 | 南昌大学 | 一种微流道装置和该装置制备的高载油微胶囊及其方法 |
| US12415172B2 (en) | 2022-12-22 | 2025-09-16 | Synthego Corporation | Systems and method for automated oligonucleotide synthesis |
| CN116212713A (zh) * | 2023-03-20 | 2023-06-06 | 重庆多敏生物科技有限公司 | 一种模块化连续液相合成混匀系统 |
| WO2024248745A2 (en) * | 2023-05-31 | 2024-12-05 | Pi̇ka Research Araştirma Geli̇şti̇rme Teknoloji̇ İmalat Ltd.Şti̇. | A disintegration system for paraffin used in wood veneer and a disintegrating tube |
| CN119633633B (zh) * | 2023-09-18 | 2026-07-17 | 墨格微流科技(汕头)有限公司 | 一种水分散神经酰胺产品及其制备方法与制备系统 |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4533254A (en) | 1981-04-17 | 1985-08-06 | Biotechnology Development Corporation | Apparatus for forming emulsions |
| US4908154A (en) | 1981-04-17 | 1990-03-13 | Biotechnology Development Corporation | Method of forming a microemulsion |
| US6159442A (en) * | 1997-08-05 | 2000-12-12 | Mfic Corporation | Use of multiple stream high pressure mixer/reactor |
| US6186193B1 (en) * | 1996-11-15 | 2001-02-13 | Oden Corporation | Continuous liquid stream digital blending system |
| US20030206959A9 (en) | 2000-12-22 | 2003-11-06 | Kipp James E. | Method for preparing submicron particle suspensions |
| US20040266890A1 (en) | 2003-03-24 | 2004-12-30 | Kipp James E. | Methods and apparatuses for the comminution and stabilization of small particles |
| WO2005018687A2 (en) | 2003-08-19 | 2005-03-03 | Resolution Chemicals Limited | Particle-size reduction apparatus, and use thereof |
| US6977085B2 (en) | 2000-12-22 | 2005-12-20 | Baxter International Inc. | Method for preparing submicron suspensions with polymorph control |
| US7829039B2 (en) * | 2005-04-05 | 2010-11-09 | Forschungszentrum Karlsruhe Gmbh | Mixer system, reactor and reactor system |
| US8187554B2 (en) * | 2008-04-23 | 2012-05-29 | Microfluidics International Corporation | Apparatus and methods for nanoparticle generation and process intensification of transport and reaction systems |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3282731B2 (ja) | 1990-06-15 | 2002-05-20 | メルク エンド カムパニー インコーポレーテッド | 結晶の構造および大きさを改良する結晶化方法 |
| US5578279A (en) | 1992-10-06 | 1996-11-26 | Merck & Co., Inc. | Dual jet crystallizer apparatus |
| CZ20011726A3 (cs) | 2000-05-26 | 2002-02-13 | Pfizer Products Inc. | Způsob reakční krystalizace, který umoľňuje řídit velikost částic |
| US20060151899A1 (en) | 2003-08-06 | 2006-07-13 | Akira Kato | Process for producing drug ultramicroparticle and apparatus therefor |
| JP2009067999A (ja) | 2007-08-21 | 2009-04-02 | Kyoto Univ | Mw/Mnが1.25以下であるポリマーの製造方法 |
| JP6269581B2 (ja) | 2015-06-02 | 2018-01-31 | トヨタ自動車株式会社 | 燃料電池電極用コアシェル触媒の製造方法 |
| EP3664785A4 (en) * | 2018-06-22 | 2022-01-12 | Delphi Scientific, LLC | DEVICE, SYSTEMS AND PROCESSES FOR CONTINUOUS PRODUCTION OF NANOMATERIALS AND HIGH PURITY CHEMICALS |
-
2019
- 2019-06-24 EP EP19822688.8A patent/EP3664785A4/en active Pending
- 2019-06-24 WO PCT/US2019/038705 patent/WO2019246615A1/en not_active Ceased
- 2019-06-24 CA CA3075827A patent/CA3075827C/en active Active
- 2019-06-24 JP JP2020570488A patent/JP7320852B2/ja active Active
- 2019-06-24 US US16/624,631 patent/US11191723B2/en active Active
-
2020
- 2020-03-12 IL IL273251A patent/IL273251B/en unknown
-
2021
- 2021-11-01 US US17/516,174 patent/US12036320B2/en active Active
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4533254A (en) | 1981-04-17 | 1985-08-06 | Biotechnology Development Corporation | Apparatus for forming emulsions |
| US4908154A (en) | 1981-04-17 | 1990-03-13 | Biotechnology Development Corporation | Method of forming a microemulsion |
| US6186193B1 (en) * | 1996-11-15 | 2001-02-13 | Oden Corporation | Continuous liquid stream digital blending system |
| US6159442A (en) * | 1997-08-05 | 2000-12-12 | Mfic Corporation | Use of multiple stream high pressure mixer/reactor |
| US20030206959A9 (en) | 2000-12-22 | 2003-11-06 | Kipp James E. | Method for preparing submicron particle suspensions |
| US6977085B2 (en) | 2000-12-22 | 2005-12-20 | Baxter International Inc. | Method for preparing submicron suspensions with polymorph control |
| US20040266890A1 (en) | 2003-03-24 | 2004-12-30 | Kipp James E. | Methods and apparatuses for the comminution and stabilization of small particles |
| WO2005018687A2 (en) | 2003-08-19 | 2005-03-03 | Resolution Chemicals Limited | Particle-size reduction apparatus, and use thereof |
| US7829039B2 (en) * | 2005-04-05 | 2010-11-09 | Forschungszentrum Karlsruhe Gmbh | Mixer system, reactor and reactor system |
| US8187554B2 (en) * | 2008-04-23 | 2012-05-29 | Microfluidics International Corporation | Apparatus and methods for nanoparticle generation and process intensification of transport and reaction systems |
Non-Patent Citations (1)
| Title |
|---|
| See also references of EP3664785A4 |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111359540A (zh) * | 2020-04-08 | 2020-07-03 | 福州大学 | 用于微反应器的无脉动浆料进料装置及使用方法 |
| EP4582176A3 (en) * | 2021-11-03 | 2025-10-15 | leon-nanodrugs GmbH | Apparatus and method for mixing small liquid volumes, and use of the apparatus |
Also Published As
| Publication number | Publication date |
|---|---|
| CA3075827A1 (en) | 2019-12-26 |
| US11191723B2 (en) | 2021-12-07 |
| EP3664785A1 (en) | 2020-06-17 |
| IL273251B (en) | 2022-04-01 |
| IL273251A (en) | 2020-04-30 |
| US12036320B2 (en) | 2024-07-16 |
| EP3664785A4 (en) | 2022-01-12 |
| US20200397696A1 (en) | 2020-12-24 |
| CA3075827C (en) | 2021-11-16 |
| JP2021527561A (ja) | 2021-10-14 |
| JP7320852B2 (ja) | 2023-08-04 |
| US20220047510A1 (en) | 2022-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12036320B2 (en) | Apparatus, systems, and methods for continuous manufacturing of nanomaterials and high purity chemicals | |
| CA2720921C (en) | Apparatus and methods for nanoparticle generation and process intensification of transport and reaction systems | |
| Jahn et al. | Preparation of nanoparticles by continuous-flow microfluidics | |
| Páez-Hernández et al. | Developing curcumin nanoemulsions by high-intensity methods: Impact of ultrasonication and microfluidization parameters | |
| Okushima et al. | Controlled production of monodisperse double emulsions by two-step droplet breakup in microfluidic devices | |
| VandenBerg et al. | Learning from the future: towards continuous manufacturing of nanomaterials | |
| JP2007503993A (ja) | 表面リアクタの操作方法およびこの方法を用いるリアクタ | |
| EP2210658A1 (en) | Method of producing emulsion and emulsion obtained thereby | |
| Köhler et al. | High pressure emulsification with nano-particles as stabilizing agents | |
| Liu et al. | Continuous antisolvent crystallization of dolutegravir sodium using microfluidics | |
| D’oria et al. | Preparation of solid lipid particles by membrane emulsification—Influence of process parameters | |
| JP2006520678A (ja) | 乳濁液または分散液を連続的に作製するための装置および方法 | |
| Minetti et al. | Generation of curcumin-loaded albumin nanoparticles by using off-the-shelf microfluidics driven by gravity | |
| Xu et al. | Nanoprecipitation-induced formation of nanoparticles for drug delivery | |
| Benyahia et al. | Experimental and computational analysis of mixing inside droplets for microfluidic fabrication of gold nanoparticles | |
| WO2010112379A1 (en) | Method and apparatus for the manufacture of a colloidal dispersion using controlled micro-channel flow | |
| Godary et al. | High throughput synthesis of liposomes using vibrating sharp-tip mixing | |
| JP2009082832A (ja) | 静止型混合器 | |
| Rosalba et al. | A modular flow process intensification towards lipid peptoids nano assembly formation | |
| Chomistek et al. | Large scale nanomaterial production using microfluidizer high shear processing | |
| Amarasiri et al. | Emulsion Techniques for Nanoparticle Production | |
| Panagiotou et al. | Bottom up nano-particle formation via controlled crystallization and chemical reactions | |
| Zheng et al. | Microfluidics to Prepare Polymeric Nanoparticles | |
| Caccavo et al. | Process-guided design of nanoliposomal vitamin D3: formulation, stability and quality by design mapping | |
| Izumida et al. | Production of quasi-monodisperse emulsions with large droplets using a micromachined device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 19822688 Country of ref document: EP Kind code of ref document: A1 |
|
| ENP | Entry into the national phase |
Ref document number: 3075827 Country of ref document: CA |
|
| ENP | Entry into the national phase |
Ref document number: 2019822688 Country of ref document: EP Effective date: 20200313 |
|
| ENP | Entry into the national phase |
Ref document number: 2020570488 Country of ref document: JP Kind code of ref document: A |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |